AU2001268039A1 - Bis-arylsulfones - Google Patents

Bis-arylsulfones

Info

Publication number
AU2001268039A1
AU2001268039A1 AU2001268039A AU2001268039A AU2001268039A1 AU 2001268039 A1 AU2001268039 A1 AU 2001268039A1 AU 2001268039 A AU2001268039 A AU 2001268039A AU 2001268039 A AU2001268039 A AU 2001268039A AU 2001268039 A1 AU2001268039 A1 AU 2001268039A1
Authority
AU
Australia
Prior art keywords
arylsulfones
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001268039A
Other versions
AU2001268039B2 (en
Inventor
E. Jon Jacobsen
Stephen J. King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co Inc
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US21289400P priority Critical
Priority to US60/212,894 priority
Priority to US23702500P priority
Priority to US60/237,025 priority
Priority to US23971300P priority
Priority to US60/239,713 priority
Priority to US60/268,261 priority
Priority to US26826101P priority
Priority to PCT/US2001/010848 priority patent/WO2001098279A2/en
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of AU2001268039A1 publication Critical patent/AU2001268039A1/en
Application granted granted Critical
Publication of AU2001268039B2 publication Critical patent/AU2001268039B2/en
Application status is Ceased legal-status Critical
Anticipated expiration legal-status Critical

Links

AU2001268039A 2000-06-20 2001-06-08 Bis-arylsulfones Ceased AU2001268039B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US21289400P true 2000-06-20 2000-06-20
US60/212,894 2000-06-20
US23702500P true 2000-09-29 2000-09-29
US60/237,025 2000-09-29
US23971300P true 2000-10-12 2000-10-12
US60/239,713 2000-10-12
US26826101P true 2001-02-13 2001-02-13
US60/268,261 2001-02-13
PCT/US2001/010848 WO2001098279A2 (en) 2000-06-20 2001-06-08 Bis-arylsulfones

Publications (2)

Publication Number Publication Date
AU2001268039A1 true AU2001268039A1 (en) 2002-03-21
AU2001268039B2 AU2001268039B2 (en) 2005-06-09

Family

ID=27498914

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001268039A Ceased AU2001268039B2 (en) 2000-06-20 2001-06-08 Bis-arylsulfones
AU6803901A Pending AU6803901A (en) 2000-06-20 2001-06-08 Bis-arylsulfones

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU6803901A Pending AU6803901A (en) 2000-06-20 2001-06-08 Bis-arylsulfones

Country Status (13)

Country Link
US (3) US20030225065A1 (en)
EP (1) EP1294701A2 (en)
JP (1) JP2004501141A (en)
KR (1) KR20030011093A (en)
CN (1) CN1217938C (en)
AR (2) AR028705A1 (en)
AU (2) AU2001268039B2 (en)
BR (1) BR0111892A (en)
CA (1) CA2410447A1 (en)
MX (1) MXPA02012626A (en)
NZ (1) NZ523314A (en)
PE (1) PE20020063A1 (en)
WO (1) WO2001098279A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020063A1 (en) * 2000-06-20 2002-01-30 Upjohn Co Bis-sulfones as ligands of the 5-HT receptor
RU2268884C2 (en) * 2001-08-10 2006-01-27 Ф.Хоффманн-Ля Рош Аг Arylsulfonyl derivatives possessing affinity to 5-ht6 receptor and method for their preparing
JP2005528587A (en) * 2002-02-01 2005-09-22 バイエル・ヘルスケア・アクチェンゲゼルシャフトBayer HealthCare AG Diagnostic and therapeutic substances for diseases associated with the novel human 5-HT6 receptor
EP1956004B1 (en) 2002-03-27 2012-06-13 Glaxo Group Limited Quinoline derivatives and their use as 5-HT6 ligands
US20040029865A1 (en) * 2002-05-23 2004-02-12 Acker Brad A. Bis-arylsulfones
DE10224556A1 (en) * 2002-05-31 2004-01-08 Grünenthal GmbH Medicament containing 1-dimethylamino-3- (3-methoxy-phenyl) 2-methyl-pentan-3-ol in various formulations
AU2003259246A1 (en) * 2002-07-29 2004-02-16 Rajiv Doshi Methods for the use of neurotoxin in the treatment of urologic disorders
AT313532T (en) 2003-07-22 2006-01-15 Arena Pharm Inc Diaryl and arylheteroaryl drug derivatives as modulators of the 5-ht2a serotonin receptor suitable for the prophylaxis and treatment of related diseases thereof
US20050201965A1 (en) * 2004-03-11 2005-09-15 The Procter & Gamble Company Personal cleansing compositions
CN101203500B (en) 2005-01-25 2013-08-21 格利尼公司 Substituted arylamine compounds and uses as 5-HT6 moderator thereof
AU2006209216A1 (en) * 2005-01-25 2006-08-03 Galenea Corp Substituted arylamine compounds and their use as 5-HT6 modulators
CN102617513B (en) 2006-06-16 2015-09-23 H.隆德贝克有限公司 As be used for the treatment of cognitive impairment, 1-[2-(2, the 4-dimethylphenylsulfanyl)-phenyl] piperazine of the compound to serotonin reabsorption, 5-HT3 and 5-HT1A activity with combination
KR20090079259A (en) 2006-11-09 2009-07-21 에프. 호프만-라 로슈 아게 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors
WO2009058238A1 (en) * 2007-10-29 2009-05-07 Merck & Co., Inc. Substituted diazepan orexin receptor antagonists
WO2009074607A1 (en) 2007-12-12 2009-06-18 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
RU2443697C1 (en) * 2010-12-21 2012-02-27 Александр Васильевич Иващенко Substituted methyl-amines, serotonin 5-ht6 receptor antagonists, methods of production and use
WO2013049272A2 (en) 2011-09-29 2013-04-04 Theraceutix, Llc Composition and method for treatment of symptoms associated with various skin conditions
CN109562085A (en) 2015-06-12 2019-04-02 阿速万科学有限责任公司 For preventing and treating the diaryl and aryl heteroaryl urea derivative of REM sleep behavior disorder
CA2992518A1 (en) 2015-07-15 2017-01-19 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851423A (en) 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
GB8914660D0 (en) 1989-06-26 1989-08-16 Fujisawa Pharmaceutical Co Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same
WO1992006683A1 (en) 1990-10-22 1992-04-30 Research Corporation Technologies, Inc. Aryl and heteroaryl compounds having anti-retrovirus activity
AT159009T (en) 1991-05-10 1997-10-15 Rhone Poulenc Rorer Int To mono- and bicyclic aryl and heteroaryl derivatives having an inhibitory effect on the EGF and / or PDGF receptor tyrosine kinase
WO1993017682A1 (en) 1992-03-04 1993-09-16 Abbott Laboratories Angiotensin ii receptor antagonists
WO1993018035A1 (en) 1992-03-04 1993-09-16 Abbott Laboratories Angiotensin ii receptor antagonists
EP0666253A4 (en) 1992-10-21 1996-04-10 Taisho Pharma Co Ltd N-t-BUTYLANILINE ANALOG AND LIPID LEVEL DEPRESSANT CONTAINING THE SAME.
DE4238994A1 (en) 1992-11-19 1994-05-26 Basf Ag Aniline as markers for mineral oils
JPH0733735A (en) * 1993-07-26 1995-02-03 Green Cross Corp:The Novel diphenylsulfone derivative
WO1997007790A1 (en) 1995-08-28 1997-03-06 Interlab Corporation Pharmaceutical compositions for the treatment of infectious diseases
HUT76266A (en) * 1995-10-31 1997-07-28 Egyt Gyogyszervegyeszeti Gyar New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components
AU736256B2 (en) 1997-07-11 2001-07-26 Smithkline Beecham Plc Novel compounds
GB9801392D0 (en) 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
GB9803411D0 (en) 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds
US6100291A (en) 1998-03-16 2000-08-08 Allelix Biopharmaceuticals Inc. Pyrrolidine-indole compounds having 5-HT6 affinity
GB9818914D0 (en) 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
PE20020063A1 (en) * 2000-06-20 2002-01-30 Upjohn Co Bis-sulfones as ligands of the 5-HT receptor

Similar Documents

Publication Publication Date Title
AU2002246855A1 (en) Novel compounds
AU2002363250A1 (en) Pyrazole-amides and-sulfonamides
AU2002337489A1 (en) Inexsufflator
AU2001260301A1 (en) Novel phenyl-propargylether derivatives
AU2001270017A1 (en) Liveexception system
AU2001248603A1 (en) Can end
AU2001260537A1 (en) 2-aminocarbonyl-9H-purine derivatives
AU2001283005A1 (en) Iso-truss structure
AU2001271211A2 (en) Case
AU2001271211A1 (en) Case
AU2002343483A1 (en) Hydroxypropylamines
AU2001233918A1 (en) Pyridinylimidazoles
AU6419701A (en) Electropancreatography
AU2002343482A1 (en) Prolyl-4-hydroxylases
AU2001282743A1 (en) Electro-powder
AUPQ605800A0 (en) Printehead assembly
AU2001260212A1 (en) Composition
AUPQ998100A0 (en) Application development
AU2001266345A1 (en) Five-membered-ring compound
AU2002331469A1 (en) Non-starch-polysaccharides
AU2001258224A1 (en) Wavepowermachine
AU2001292619A1 (en) Novel compounds
AU2002363368A1 (en) Hydrazono-malonitriles
AU2001268039A1 (en) Bis-arylsulfones
AU2002313565A1 (en) Putter-heads